Perspective Pharmacovigilance, Inc. and RegDev, Inc. Announce Strategic Partnership to Provide Best-in-Class Molecule to Market Services

FOR IMMEDIATE RELEASE

San Francisco, California 12-MAR-2024 – With Perspective Pharmacovigilance having supported safety and pharmacovigilance activities for over 150 products since its inception in 2017 and boasting a remarkable client retention rate, and RegDev having supported 210 clients during their drug development journey, resulting in approval of products in North America, Europe, and Asia, this partnership represents a unique opportunity for clients to access premier support for their pharmacovigilance, regulatory, and quality needs.

Rooted in shared philosophies, both companies prioritize hiring and retaining leading subject matter experts with an average of over 20-years of industry experience, with prior experience as department heads and/or regulators. This collaboration represents a union of strong expertise, a commitment to excellence, and ethical practices.

Perspective Pharmacovigilance’s comprehensive pharmacovigilance services are complemented by RegDev’s strategic regulatory guidance and clinical strategy, resulting in a seamless integration of pre-market and post-market regulatory activities. By combining these services, clients can expect streamlined processes, enhanced compliance, and accelerated time-to-market for their products.

“Leveraging the expertise of both organizations allows us to offer a level of service and expertise unmatched by our competitors, ensuring our clients have the support they need to navigate drug development challenges effectively.  Both organizations share a similar approach of offering boutique services that can be customized to meet client needs.” said Bethany Van Veen, Founder and CEO of Perspective Pharmacovigilance.

Likewise, Sid Senroy, Founder and President of RegDev, expressed excitement for the collaboration, stating, “Our combined strengths position us as leaders in the clinical development and commercial space. With our depth of experience and commitment to excellence, we are well-equipped to deliver exceptional value to our clients and help them achieve their regulatory goals.”

The synergy between Perspective Pharmacovigilance and RegDev will enable clients to benefit from a holistic approach to regulatory and quality affairs, clinical development and pharmacovigilance setting a new standard offering a more flexible and cost-effective solution than the traditional contract research organization.  By combining pharmacovigilance excellence with regulatory strategy expertise, the partnership aims to redefine regulatory support and drive success for pharmaceutical companies worldwide.

For more information about Perspective Pharmacovigilance, Inc and RegDev, Inc, please visit www.perspectivepv.com and www.regdevinc.com, respectively.

About Perspective Pharmacovigilance, Inc.

Perspective Pharmacovigilance, Inc. is a leading provider of pharmacovigilance services, specializing in drug safety operations, safety sciences and risk management, and compliance monitoring for pharmaceutical and biotechnology companies worldwide. With a commitment to patient safety and compliance, Perspective Pharmacovigilance enables clients to navigate complex pharmacovigilance landscapes seamlessly.

About RegDev, Inc

RegDev, Inc is a premier drug development consulting firm, offering strategic guidance and strategic drug development services to pharmaceutical and biotech companies across the globe to support them through the entire drug development lifecycle. With expertise in quality and compliance, clinical operations and development, and regulatory development and strategy, RegDev empowers clients to navigate regulatory pathways efficiently and achieve timely approvals across various jurisdictions.